Back to search

Article

The impact of dapagliflozin for the myocardial metabolomic profiles of mice with chronic heart failure induced by a high fat diet

2025-06-25

Abstract excerpt

<title>Abstract</title> <p>Background The molecular mechanisms responsible for the clinical benefits of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in patients with heart failure and a reduced or preserved ejection fraction, both diabetic and non-diabetic, are still not fully understood. This study aimed to examine the myocardial metabolomic profiles of mice with chronic heart failure induced by high-fat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cb3d32e2-1bcd-53a4-9619-4ce0ba3dc7c6
DOI
10.21203/rs.3.rs-6881055/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The impact of dapagliflozin for the myocardial metabolomic profiles of mice with chronic heart failure induced by a high fat dietDOI 10.21203/rs.3.rs-6881055/v1
Combined Semaglutide and Exercise Ameliorate HFpEF-Associated MASH: Multi-Omics InsightsSemantic proximity
Obesity and diabetes related disturbances in systemic metabolism induce a cardiometabolic heart failure with preserved ejection fraction phenotype in a combined high-fat, high sucrose diet and streptozotocin mouse modelSemantic proximity
Gastrodin attenuates diabetic cardiomyopathy characterised by myocardial fibrosis by inhibiting the KLK8-PAR1 signalling axisSemantic proximity
Dapagliflozin-affected endothelial dysfunction and altered gut microbiota in mice with heart failureSemantic proximity
Dapagliflozin Ameliorates Myocardial Ischemia/Reperfusion Injury by Modulating EGFR Signaling and Targeting NCOA4-mediated FerritinophagySemantic proximity
Sodium-glucose co-transporter 2 Inhibitors Act Independently of <i>SGLT2</i> to Confer Benefit for Heart Failure with Reduced Ejection Fraction in MiceSemantic proximity
Targeting Metabolic Dysfunction and Inflammation with Sotagliflozin Reverses Diastolic Dysfunction in Experimental HFpEFSemantic proximity
A systems‑level scoping review of multi‑omic markers in obesity‑ and type 2 diabetes‑associated diastolic dysfunction: An integrated three‑module frameworkSemantic proximity
GDF11 alleviates pathological myocardial remodeling in diabetic cardiomyopathy through SIRT1-dependent regulation of oxidative stress and apoptosisSemantic proximity
Type 2 diabetes worsens the outcome of ischemia/reperfusion in female STEMI patients and female db/db mice with HFpEF cardiometabolic phenotypeSemantic proximity
Impaired cardiac branched-chain amino acid metabolism in a novel model of diabetic cardiomyopathy.Semantic proximity
Potential role of the mTOR-C1-PGC1α-PPARα axis under type-II diabetes and hypertension in the human heartSemantic proximity
Select a neighboring publication to make it the new centre.